Marker Therapeutics, Inc. - Common Stock — Flux de trésorerie (NASDAQ:MRKR) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -18.86 M-27.28 M-26.97 M-16.44 M-10.91 M-12.01 M -7.92 M Flux de trésorerie liés aux activités d'investissement -10.43 M-3.13 M-4.95 M18.66 M18.66 M— — Flux de trésorerie liés aux activités de financement 6.74 M52.56 M202.13 K1.11 M14.99 M9.86 M — Flux de trésorerie disponible -18.86 M-27.28 M-26.97 M-16.44 M-10.91 M-12.01 M -7.92 M

Nouvelles

MARKER THERAPEUTICS (MRKR) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright réitère sa recommandation d’achat sur l’action Marker Therapeutics

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates

H.C. Wainwright réitère sa recommandation d’achat sur Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Marker Therapeutics fixe la date de l’assemblée annuelle des actionnaires 2026

Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?